Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L C Edelstein

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Molecular and Cellular Biology|March 25, 2000
The Rel/NF-kappaB family directly activates expression of the apoptosis inhibitor Bcl-x(L)C Chen, L C Edelstein, C Gélinas
Genes & Development|February 27, 1999
The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappaB that blocks TNFalpha-induced apoptosisW X Zong, L C Edelstein, C Chen, et al.
Journal of Thrombosis and Haemostasis : JTH|July 2, 2013
MicroRNAs in platelet production and activationL C Edelstein, S E McKenzie, C Shaw, et al.
Journal of Thrombosis and Haemostasis : JTH|October 23, 2018
The protease-activated receptor 4 Ala120Thr variant alters platelet responsiveness to low-dose thrombin and protease-activated receptor 4 desensitization, and is blocked by non-competitive P2Y<sub>12</sub> inhibitionM J Whitley, D M Henke, A Ghazi, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Molecular and Cellular Biology|March 25, 2000
The Rel/NF-kappaB family directly activates expression of the apoptosis inhibitor Bcl-x(L)C Chen, L C Edelstein, C Gélinas
Genes & Development|February 27, 1999
The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappaB that blocks TNFalpha-induced apoptosisW X Zong, L C Edelstein, C Chen, et al.
Journal of Thrombosis and Haemostasis : JTH|July 2, 2013
MicroRNAs in platelet production and activationL C Edelstein, S E McKenzie, C Shaw, et al.
Journal of Thrombosis and Haemostasis : JTH|October 23, 2018
The protease-activated receptor 4 Ala120Thr variant alters platelet responsiveness to low-dose thrombin and protease-activated receptor 4 desensitization, and is blocked by non-competitive P2Y<sub>12</sub> inhibitionM J Whitley, D M Henke, A Ghazi, et al.
Pageof 1